These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 2125237

  • 1. Lithium carbonate augmentation of desipramine in refractory depression.
    Dallal A, Fontaine R, Ontiveros A, Elie R.
    Can J Psychiatry; 1990 Oct; 35(7):608-11. PubMed ID: 2125237
    [Abstract] [Full Text] [Related]

  • 2. Refractory depression: the addition of lithium to fluoxetine or desipramine.
    Ontiveros A, Fontaine R, Elie R.
    Acta Psychiatr Scand; 1991 Mar; 83(3):188-92. PubMed ID: 1903237
    [Abstract] [Full Text] [Related]

  • 3. Lithium carbonate augmentation of desipramine and fluoxetine in refractory depression.
    Fontaine R, Ontiveros A, Elie R, Vézina M.
    Biol Psychiatry; 1991 May 01; 29(9):946-8. PubMed ID: 1904782
    [No Abstract] [Full Text] [Related]

  • 4. Sequence of drug administration in lithium augmentation: a case study.
    Price LH, Delgado PL, Charney DS, Heninger GR.
    J Clin Psychiatry; 1988 Apr 01; 49(4):161-2. PubMed ID: 3356674
    [Abstract] [Full Text] [Related]

  • 5. Fenfluramine augmentation in tricyclic-refractory depression.
    Price LH, Charney DS, Delgado PL, Heninger GR.
    J Clin Psychopharmacol; 1990 Oct 01; 10(5):312-7. PubMed ID: 2258448
    [Abstract] [Full Text] [Related]

  • 6. Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study.
    Fava M, Rosenbaum JF, McGrath PJ, Stewart JW, Amsterdam JD, Quitkin FM.
    Am J Psychiatry; 1994 Sep 01; 151(9):1372-4. PubMed ID: 8067495
    [Abstract] [Full Text] [Related]

  • 7. Lithium and desipramine versus desipramine alone in the treatment of severe major depression: a preliminary study.
    Cappiello A, McDougle CJ, Delgado PL, Malison RT, Jatlow P, Charney DS, Heninger GR, Price LH.
    Int Clin Psychopharmacol; 1998 Sep 01; 13(5):191-8. PubMed ID: 9817623
    [Abstract] [Full Text] [Related]

  • 8. Lithium carbonate augmentation of antidepressant treatment. An effective prescription for treatment-refractory depression.
    Heninger GR, Charney DS, Sternberg DE.
    Arch Gen Psychiatry; 1983 Dec 01; 40(12):1335-42. PubMed ID: 6418110
    [Abstract] [Full Text] [Related]

  • 9. Concurrent treatment of nonresistant major depression with desipramine and lithium: a double-blind, placebo-controlled study.
    Bloch M, Schwartzman Y, Bonne O, Lerer B.
    J Clin Psychopharmacol; 1997 Feb 01; 17(1):44-8. PubMed ID: 9004056
    [Abstract] [Full Text] [Related]

  • 10. Adjunctive lithium carbonate in nortriptyline-resistant elderly depressed patients.
    Zimmer B, Rosen J, Thornton JE, Perel JM, Reynolds CF.
    J Clin Psychopharmacol; 1991 Aug 01; 11(4):254-6. PubMed ID: 1918424
    [Abstract] [Full Text] [Related]

  • 11. Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression. Correlations with the neurobiologic actions of tricyclic antidepressant drugs and lithium ion on the serotonin system.
    de Montigny C, Cournoyer G, Morissette R, Langlois R, Caillé G.
    Arch Gen Psychiatry; 1983 Dec 01; 40(12):1327-34. PubMed ID: 6418109
    [Abstract] [Full Text] [Related]

  • 12. Lithium augmentation in psychotic depression refractory to combined drug treatment.
    Nelson JC, Mazure CM.
    Am J Psychiatry; 1986 Mar 01; 143(3):363-6. PubMed ID: 2869701
    [Abstract] [Full Text] [Related]

  • 13. Rapid response to the addition of lithium in iprindole-resistant unipolar depression: a pilot study.
    de Montigny C, Elie R, Caillé G.
    Am J Psychiatry; 1985 Feb 01; 142(2):220-3. PubMed ID: 3918468
    [Abstract] [Full Text] [Related]

  • 14. [Lithium carbonate augmentation in tricyclic antidepressant-resistant depression].
    Dorevitch A, Ginath Y.
    Harefuah; 1991 Dec 01; 121(11):429-30. PubMed ID: 1786889
    [Abstract] [Full Text] [Related]

  • 15. A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression.
    Joffe RT, Singer W, Levitt AJ, MacDonald C.
    Arch Gen Psychiatry; 1993 May 01; 50(5):387-93. PubMed ID: 8489327
    [Abstract] [Full Text] [Related]

  • 16. After lithium augmentation: a retrospective follow-up of patients with antidepressant-refractory depression.
    Nierenberg AA, Price LH, Charney DS, Heninger GR.
    J Affect Disord; 1990 Mar 01; 18(3):167-75. PubMed ID: 2139061
    [Abstract] [Full Text] [Related]

  • 17. Lithium augmentation of the effects of desipramine in a mouse model of treatment-resistant depression: a role for hippocampal cell proliferation.
    O'Leary OF, Zandy S, Dinan TG, Cryan JF.
    Neuroscience; 2013 Jan 03; 228():36-46. PubMed ID: 23069753
    [Abstract] [Full Text] [Related]

  • 18. Low dosage lithium augmentation in venlafaxine resistant depression: an open-label study.
    Alevizos B, Alevizos E, Leonardou A, Zervas I.
    Psychiatriki; 2012 Jan 03; 23(2):143-8. PubMed ID: 22796912
    [Abstract] [Full Text] [Related]

  • 19. Variability of response to lithium augmentation in refractory depression.
    Price LH, Charney DS, Heninger GR.
    Am J Psychiatry; 1986 Nov 03; 143(11):1387-92. PubMed ID: 3096155
    [Abstract] [Full Text] [Related]

  • 20. Lithium as an adjunct in the treatment of major depression.
    Browne M, Lapierre YD, Hrdina PD, Horn E.
    Int Clin Psychopharmacol; 1990 Apr 03; 5(2):103-10. PubMed ID: 2116474
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.